Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Veronica Dal Bo"'
Autor:
Manuela Verri, Francesco Paolo Fanizzi, Graziella Bernocchi, Maddalena Grimaldi, Maria Grazia Bottone, Beatrice Ferrari, Paola Veneroni, Sandra Angelica De Pascali, Fabrizio De Luca, Elisa Roda, Sergio Barni, Veronica Dal Bo
Publikováno v:
Toxicology and Applied Pharmacology. 364:1-11
Cisplatin (cisPt), among the best known components of multi-drug front-line therapies used for the treatments of solid tumors, such as the childhood neuroblastoma, acts through DNA linking. Nevertheless, the cisPt effectiveness is compromised by the
Autor:
Alessandra Esposito, Violetta Insolia, Francesco Paolo Fanizzi, Graziella Bernocchi, Valeria Maria Piccolini, Sandra Angelica De Pascali, Veronica Dal Bo, Maria Grazia Bottone
Publikováno v:
International Journal of Developmental Neuroscience. 40:24-34
Several chemotherapeutic drugs are known to cause neurotoxicity. Platinum-based agents in use or in clinical trials display neurotoxic potential accompanied by neurological complications; recent studies have identified a large number of behavioural i
Autor:
Valeria Maria Piccolini, Maria Grazia Bottone, Veronica Dal Bo, Giada Santin, Vincenzo Giansanti, Paola Veneroni, Graziella Bernocchi, Sergio Barni
Publikováno v:
NeuroToxicology. 34:51-60
Cisplatin induces apoptosis through different pathways. The intrinsic apoptotic pathway is mediated by mitochondria, which, as a result of cisplatin treatment, undergo morphological alterations. The aim of this study was to investigate cisplatin-indu
Autor:
Veronica Dal Bo, Violetta Insolia, Maria Grazia Bottone, Sergio Barni, Paola Veneroni, Graziella Bernocchi, Francesco Paolo Fanizzi, Maddalena Grimaldi, Manuela Verri, Valeria Maria Piccolini, Sandra Angelica De Pascali, Giada Santin
Publikováno v:
Histochemistry and cell biology. 145(5)
Cisplatin is one of the most active chemotherapeutic agents used in the treatment of childhood and adult malignancies. Cisplatin induces cell death through different pathways. Despite its effectiveness, the continued clinical use of cisplatin is limi
Autor:
Bottone, Maria Grazia1,2 bottone@unipv.it, Veronica, Dal Bo1 veronica.dalbo01@ateneopv.it, Piccolini, Valeria Maria1 valeria.piccolini@unipv.it, Bottiroli, Giovanni2 bottiroli@igm.cnr.it, De Pascali, Sandra Angelica3 sandra.depascali@unisalento.it, Fanizzi, Francesco Paolo3 fp.fanizzi@unisalento.it, Bernocchi, Graziella1 graziella.bernocchi@unipv.it
Publikováno v:
Journal of Chemical Neuroanatomy. Dec2012, Vol. 46 Issue 1/2, p19-29. 11p.